Ilaria Zampiva

Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study

Cristina Masini, Cinzia Iotti, Ugo De Giorgi et al. · European Urology · 2021 · 105 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis

Giuseppe Bronte, Elisabetta Petracci, Serena De Matteis et al. · Frontiers in Immunology · 2022 · 48 citations · Full text

Medicine, Immunology, Oncology +16

Nivolumab (NIVO) in combination with stereotactic body radiotherapy (SBRT) in pretreated patients (pts) with metastatic renal cell carcinoma (mRCC): First results of phase II NIVES study.

Cristina Masini, Cinzia Iotti, Ugo De Giorgi et al. · Journal of Clinical Oncology · 2020 · 35 citations

Medicine, Oncology, Radiation Oncology +17

Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic

Serena Zuliani, Ilaria Zampiva, Daniela Tregnago et al. · European Journal of Cancer · 2020 · 31 citations · Full text

Medicine, Infectious Diseases, Oncology +13

Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)

Matteo Santoni, Francesco Massari, Zin Myint et al. · Clinical Genitourinary Cancer · 2023 · 31 citations · Full text

Medicine, Oncology, Pathology +15